Blood platelet trends may reveal hidden risk in autoimmune disease

This study investigates whether changes in platelet counts over time can serve as a dynamic biomarker for disease severity and survival in people with antiphospholipid syndrome (APS), an autoimmune condition that increases blood clot risk. Researchers will track platelet counts from routine visits and hospitalizations in 200 adults with APS, grouping patients into patterns such as stable normal, transient, fluctuating, or persistent low platelet levels. The goal is to see if these patterns correlate with the risk of death or recurrent blood clots, potentially offering a simple way to identify those who need closer monitoring.